Jonathan Yong
Stock Analyst at UBS
(3.18)
# 1,131
Out of 4,711 analysts
110
Total ratings
57.89%
Success rate
9.54%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Initiates: Neutral | $5.5 | $8.32 | -33.89% | 4 | Dec 4, 2024 | |
| CLOV Clover Health Investments | Initiates: Neutral | $4 | $3.23 | +23.84% | 3 | Oct 7, 2024 | |
| OSCR Oscar Health | Initiates: Neutral | $23 | $14.09 | +63.24% | 7 | Oct 7, 2024 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $21.76 | +14.89% | 2 | Aug 24, 2023 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $33 → $30 | $9.55 | +214.14% | 5 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $7.65 | +56.86% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $4.44 | +80.18% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $17.91 | +45.17% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $26.20 | -46.56% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $69.82 | +37.50% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $32 | $19.06 | +67.89% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $22.94 | +357.72% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $94.45 | -15.30% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $228.61 | +1.05% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $84.47 | +19.57% | 5 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $9.44 | +186.02% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $3.48 | +331.03% | 5 | Jun 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $35 → $38 | $30.86 | +23.14% | 2 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $118.28 | -15.45% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $579.74 | -22.38% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $4.18 | +187.08% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $7.87 | +789.45% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $11.30 | +50.44% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $294.73 | +18.75% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $37.90 | +150.66% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $12.78 | -33.49% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $20.07 | +104.29% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $12.52 | +35.78% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.16 | +168.99% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $81.61 | +4.15% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $153.10 | -4.64% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $59.58 | +77.91% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $180.11 | -12.83% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $276.92 | +32.89% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $247.10 | +156.98% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $44.36 | +163.75% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $14.09 | +112.92% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $303.62 | -1.85% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $129.46 | -26.62% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $500.13 | -1.03% | 1 | Oct 15, 2021 |
eHealth
Dec 4, 2024
Initiates: Neutral
Price Target: $5.5
Current: $8.32
Upside: -33.89%
Clover Health Investments
Oct 7, 2024
Initiates: Neutral
Price Target: $4
Current: $3.23
Upside: +23.84%
Oscar Health
Oct 7, 2024
Initiates: Neutral
Price Target: $23
Current: $14.09
Upside: +63.24%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $21.76
Upside: +14.89%
Walgreens Boots Alliance
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $30
Current: $9.55
Upside: +214.14%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $7.65
Upside: +56.86%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $4.44
Upside: +80.18%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $17.91
Upside: +45.17%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $26.20
Upside: -46.56%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $69.82
Upside: +37.50%
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $19.06
Upside: +67.89%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $22.94
Upside: +357.72%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $94.45
Upside: -15.30%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $228.61
Upside: +1.05%
Jul 27, 2023
Reiterates: Neutral
Price Target: $101
Current: $84.47
Upside: +19.57%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $9.44
Upside: +186.02%
Jun 30, 2023
Maintains: Neutral
Price Target: $13 → $15
Current: $3.48
Upside: +331.03%
Jun 22, 2023
Maintains: Outperform
Price Target: $35 → $38
Current: $30.86
Upside: +23.14%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $118.28
Upside: -15.45%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $579.74
Upside: -22.38%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $4.18
Upside: +187.08%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $7.87
Upside: +789.45%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $11.30
Upside: +50.44%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $294.73
Upside: +18.75%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $37.90
Upside: +150.66%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $12.78
Upside: -33.49%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $20.07
Upside: +104.29%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $12.52
Upside: +35.78%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.16
Upside: +168.99%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $81.61
Upside: +4.15%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $153.10
Upside: -4.64%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $59.58
Upside: +77.91%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $180.11
Upside: -12.83%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $276.92
Upside: +32.89%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $247.10
Upside: +156.98%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $44.36
Upside: +163.75%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $14.09
Upside: +112.92%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $303.62
Upside: -1.85%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $129.46
Upside: -26.62%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $500.13
Upside: -1.03%